Freenome Completes SPAC Merger and Debuts on Nasdaq
Health
Merger / DESPAC
Merger:
Jul 21, 2026
Industry:
MEDICAL LABORATORIES
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Freenome Completes Business Combination and Debuts on Nasdaq
Brisbane, CA, USA Freenome Holdings, Inc. (Nasdaq: FRNM) has officially announced the completion of its business combination with Perceptive Capital Solutions Corp. The newly combined company, operating under the name Freenome, Inc., is set to commence trading on the Nasdaq Capital Market under the ticker symbol FRNM.
... Read on — Members only
About Freenome Holdings, Inc.
Freenome is an early cancer detection company developing blood-based tests to detect cancer when it is most treatable. The company recognizes that no single technology can identify every cancer due to the disease’s inherent heterogeneity. Freenome’s approach combines a multiomics platform that analyzes multiple signals in the blood with artificial intelligence and machine learning to tune into cancer’s subtlest clues, even at the earliest stages of the disease.
More FRNM News
Health
Daily overview of upcoming SPAC and IPO events – from initial announcement to definitive agreement and public listing.
Discover last week’s SPAC and IPO highlights, key trends, and market updates. Stay informed with SpacStar.